Silverfin false false 30/04/2024 01/05/2023 30/04/2024 K R Ilankovan 10/10/2012 V Ilankovan 10/10/2012 29 January 2025 The principal activity of the company during the financial year was that of investment property. 08247049 2024-04-30 08247049 bus:Director1 2024-04-30 08247049 bus:Director2 2024-04-30 08247049 2023-04-30 08247049 core:CurrentFinancialInstruments 2024-04-30 08247049 core:CurrentFinancialInstruments 2023-04-30 08247049 core:Non-currentFinancialInstruments 2024-04-30 08247049 core:Non-currentFinancialInstruments 2023-04-30 08247049 core:ShareCapital 2024-04-30 08247049 core:ShareCapital 2023-04-30 08247049 core:OtherCapitalReserve 2024-04-30 08247049 core:OtherCapitalReserve 2023-04-30 08247049 core:RetainedEarningsAccumulatedLosses 2024-04-30 08247049 core:RetainedEarningsAccumulatedLosses 2023-04-30 08247049 core:OtherPropertyPlantEquipment 2023-04-30 08247049 core:OtherPropertyPlantEquipment 2024-04-30 08247049 bus:OrdinaryShareClass1 2024-04-30 08247049 2023-05-01 2024-04-30 08247049 bus:FilletedAccounts 2023-05-01 2024-04-30 08247049 bus:SmallEntities 2023-05-01 2024-04-30 08247049 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 08247049 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 08247049 bus:Director1 2023-05-01 2024-04-30 08247049 bus:Director2 2023-05-01 2024-04-30 08247049 core:OtherPropertyPlantEquipment 2023-05-01 2024-04-30 08247049 2022-05-01 2023-04-30 08247049 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 08247049 bus:OrdinaryShareClass1 2022-05-01 2023-04-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 08247049 (England and Wales)

WENTWORTH CLINIC LIMITED

Unaudited Financial Statements
For the financial year ended 30 April 2024
Pages for filing with the registrar

WENTWORTH CLINIC LIMITED

Unaudited Financial Statements

For the financial year ended 30 April 2024

Contents

WENTWORTH CLINIC LIMITED

STATEMENT OF FINANCIAL POSITION

As at 30 April 2024
WENTWORTH CLINIC LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 April 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 1,345 1,495
Investment property 4 700,000 700,000
701,345 701,495
Current assets
Debtors 5 4,033 3,804
Cash at bank and in hand 100 100
4,133 3,904
Creditors: amounts falling due within one year 6 ( 646,526) ( 358,149)
Net current liabilities (642,393) (354,245)
Total assets less current liabilities 58,952 347,250
Creditors: amounts falling due after more than one year 7 0 ( 265,364)
Net assets 58,952 81,886
Capital and reserves
Called-up share capital 8 100 100
Other reserves 10 124,213 124,213
Profit and loss account ( 65,361 ) ( 42,427 )
Total shareholders' funds 58,952 81,886

For the financial year ending 30 April 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Wentworth Clinic Limited (registered number: 08247049) were approved and authorised for issue by the Board of Directors on 29 January 2025. They were signed on its behalf by:

K R Ilankovan
Director
WENTWORTH CLINIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2024
WENTWORTH CLINIC LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Wentworth Clinic Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Little Somborne Forest Lane, Hightown Hill, Ringwood, BH24 3HF, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Tangible fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Plant and machinery etc. 20 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Investment property

Investment property is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at each reporting date with changes in fair value recognised in profit or loss. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.

The fair value is determined annually by the directors on an open market value for existing use basis.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 May 2023 7,531 7,531
At 30 April 2024 7,531 7,531
Accumulated depreciation
At 01 May 2023 6,036 6,036
Charge for the financial year 150 150
At 30 April 2024 6,186 6,186
Net book value
At 30 April 2024 1,345 1,345
At 30 April 2023 1,495 1,495

4. Investment property

Investment property
£
Valuation
As at 01 May 2023 700,000
As at 30 April 2024 700,000

Valuation

The investment property was valued at £700,000 (2023: £700,000) by the directors at the date of the financial statements.

Historic cost

If the investment properties had been accounted for under the cost accounting rules, the properties would have been measured as follows:

2024 2023
£ £
Historic cost 460,629 472,145

5. Debtors

2024 2023
£ £
Prepayments 4,033 3,804

6. Creditors: amounts falling due within one year

2024 2023
£ £
Amounts owed to directors 318,342 354,311
Accruals 2,820 3,838
Other creditors 325,364 0
646,526 358,149

7. Creditors: amounts falling due after more than one year

2024 2023
£ £
Bank loans 0 265,364

8. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100 100

9. Related party transactions

Transactions with owners holding a participating interest in the entity

2024 2023
£ £
Owed to shareholders 325,364 0

The loan to the company bears no interest and there are no set repayment terms.

Transactions with the entity's directors

2024 2023
£ £
Owed to the directors 318,342 354,311

The loan to the company bears no interest and there are no set repayment terms.

10. Other reserves

Non distributable reserves

The other reserves balance at the year end which is non distributable is made up of £124,213 (2023; £124,213) in relation to fair value movements on investment properties and associated provision for deferred tax.